TrialBMC nephrology2012

Fibroblast growth factor 23 and parathyroid hormone after treatment with active vitamin D and sevelamer carbonate in patients with chronic kidney disease stage 3b, a randomized crossover trial.

Inger H Bleskestad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.